A dual-action nanomaterial uses cancer’s own chemistry to destroy tumors while leaving healthy cells unharmed.

As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...

Researchers expanded millions of cancer-targeting NK cells from a single donor, improving manufacturing for future therapies.

In a new study published in Nature Communications, a research team at the University of Oslo have examined how cancer cells ...

Postpartum breast cancer is diagnosed five to ten years after giving birth. It is associated with a higher risk of metastasis and a lower survival rate compared with women who have not been pregnant ...

Engineered yeast cells can mimic real cancer cells and be used to test new cancer immunotherapies much faster, benefiting patients.

Researchers at the Johns Hopkins Kimmel Cancer Center have discovered how certain pathogenic bacteria in gut and breast tissue can promote breast cancer development and progression by hijacking a key ...

The National Cancer Institute has quietly moved a familiar and polarizing drug into its preclinical pipeline: ivermectin, ...

Professor Chad Mirkin found that the vaccine’s carefully organized structure dramatically boosts cancer-fighting immunity.

The relationship between sugar consumption and cancer development represents one of the most concerning nutritional discoveries of recent decades. While many people understand that excessive sugar ...